Jade Biosciences, Inc. Common Stock

JBIONASDAQ • USD
15.00 USD
↘ 0.34 (2.21%)🟢LIVE (AS OF 11:50 AM EST)
🟢Market: OPEN

Jade Biosciences, Inc. Common Stock (JBIO) trades at $15.00 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest JBIO is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 16, 2026.

Open?$15.27
High?$16.23
Low?$14.64
Prev. Close?$15.34
Volume?580.7K
Avg. Volume?902.1K
VWAP?$15.07
Rel. Volume?0.64x
Bid / Ask
Bid?$14.97 × 100
Ask?$15.11 × 200
Spread?$0.14
Midpoint?$15.04
Valuation & Ratios
Market Cap?1.1B
Shares Out?63.6M
Float?54.1M
Float %?85.0%
P/E Ratio?N/A
P/B Ratio?2.41
EPS?-$1.78
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
Employees
55
Market Cap
1.0B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2025-04-29
Address
221 CRESCENT ST.
WALTHAM, MA 02453
Phone: (781) 312-3013
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
24
Piotroski F-Score?0/9Weak
Altman Z-Score?18.99Safe
Confidence?38%Very Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?19.19%High
Short Interest?10.4M
Days to Cover?14.1
Free Float54.1M
Avg Daily Volume735.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?14.93Strong
Quick Ratio?14.93Strong
Cash Ratio?3.40Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
66
2.41CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-28.0%WEAK▾
ROA?
S&P
3
-26.1%WEAK▾
Cash Flow & Enterprise
FCF?$-110213000
Enterprise Value?$954.1M
Fundamentals ratios updated end of day